Choosing health, choosing treatment: patient choice after diagnosis of localised prostate cancer

Peter Branney; Alan White; Sunjay Jain; Chris Hiley; Paul Flowers

doi:10.1016/j.urology.2009.03.015

Choosing health, choosing treatment: patient choice after diagnosis of localised prostate cancer

Peter Branney, Alan White, Sunjay Jain, Chris Hiley, Paul Flowers

Psychology

Research output: Contribution to journal › Article › peer-review

Abstract

Patient choice is nothing new,1 but it is a motif that
is increasingly mobilized by politicians, policymakers, and health service providers across much of the Western world. Despite its global resonance, we want to make the case for considering the complexity of the contexts in which patient choice is offered. In this report, we consider research in relationship to the domain of localized prostate cancer in the United Kingdom, specifically to choosing treatment after the first diagnosis.
Before making some recommendations for research, the U.K. context is elaborated through a consideration of health policy, which is then related to the changes in a specific service (the Yorkshire Cancer Centre) and research on patients’ experiences of treatment.

Original language	English
Pages (from-to)	968-971
Number of pages	4
Journal	Urology
Volume	74
Issue number	5
DOIs	https://doi.org/10.1016/j.urology.2009.03.015
Publication status	Published - 1 Nov 2009

Keywords

patient choice
choosing treatment for cancer
prostate cancer

Documents and Links

10.1016/j.urology.2009.03.015

http://researchonline.gcu.ac.uk/sls/472

Fingerprint Dive into the research topics of 'Choosing health, choosing treatment: patient choice after diagnosis of localised prostate cancer'. Together they form a unique fingerprint.

Cite this

@article{ee4419d6644f475fba612353f181a13e,

title = "Choosing health, choosing treatment: patient choice after diagnosis of localised prostate cancer",

abstract = "Patient choice is nothing new,1 but it is a motif thatis increasingly mobilized by politicians, policymakers, and health service providers across much of the Western world. Despite its global resonance, we want to make the case for considering the complexity of the contexts in which patient choice is offered. In this report, we consider research in relationship to the domain of localized prostate cancer in the United Kingdom, specifically to choosing treatment after the first diagnosis.Before making some recommendations for research, the U.K. context is elaborated through a consideration of health policy, which is then related to the changes in a specific service (the Yorkshire Cancer Centre) and research on patients{\textquoteright} experiences of treatment.",

keywords = "patient choice, choosing treatment for cancer, prostate cancer",

author = "Peter Branney and Alan White and Sunjay Jain and Chris Hiley and Paul Flowers",

note = "<p>Originally published in: Urology (2009), 74 (5), pp.968-971.</p>",

year = "2009",

month = nov,

day = "1",

doi = "10.1016/j.urology.2009.03.015",

language = "English",

volume = "74",

pages = "968--971",

journal = "Urology",

issn = "0090-4295",

publisher = "Elsevier B.V.",

number = "5",

}

TY - JOUR

T1 - Choosing health, choosing treatment: patient choice after diagnosis of localised prostate cancer

AU - Branney, Peter

AU - White, Alan

AU - Jain, Sunjay

AU - Hiley, Chris

AU - Flowers, Paul

N1 - <p>Originally published in: Urology (2009), 74 (5), pp.968-971.</p>

PY - 2009/11/1

Y1 - 2009/11/1

N2 - Patient choice is nothing new,1 but it is a motif thatis increasingly mobilized by politicians, policymakers, and health service providers across much of the Western world. Despite its global resonance, we want to make the case for considering the complexity of the contexts in which patient choice is offered. In this report, we consider research in relationship to the domain of localized prostate cancer in the United Kingdom, specifically to choosing treatment after the first diagnosis.Before making some recommendations for research, the U.K. context is elaborated through a consideration of health policy, which is then related to the changes in a specific service (the Yorkshire Cancer Centre) and research on patients’ experiences of treatment.

AB - Patient choice is nothing new,1 but it is a motif thatis increasingly mobilized by politicians, policymakers, and health service providers across much of the Western world. Despite its global resonance, we want to make the case for considering the complexity of the contexts in which patient choice is offered. In this report, we consider research in relationship to the domain of localized prostate cancer in the United Kingdom, specifically to choosing treatment after the first diagnosis.Before making some recommendations for research, the U.K. context is elaborated through a consideration of health policy, which is then related to the changes in a specific service (the Yorkshire Cancer Centre) and research on patients’ experiences of treatment.

KW - patient choice

KW - choosing treatment for cancer

KW - prostate cancer

U2 - 10.1016/j.urology.2009.03.015

DO - 10.1016/j.urology.2009.03.015

M3 - Article

VL - 74

SP - 968

EP - 971

JO - Urology

JF - Urology

SN - 0090-4295

IS - 5

ER -